Physician

Kaitlin Ann Schiavo, MD

According to 2025 Medicare claims, Kaitlin Schiavo, MD (NPI: 1508248576) practices dermatology in the Columbia, MO market, with the plurality of this provider's patient population coming from Boone, MO. This provider's primary affiliated billing organization is DERMATOLOGY CENTER OF COLUMBIA, LLC (NPI: 1982261947) and primary practice location at 65201-8136.

Schiavo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,155 traditional Medicare patients, billed 14,946 HCPCS/CPT codes, and received $462,350 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,704 prescription claims across 639 beneficiaries totaling $633,088 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 183 records totaling $3,312. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $17,675 to $462,350. Similarly, Part D prescription costs have risen steadily, from $5,492 to $633,088. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$231K$462K2019 Medicare payment: $17,675 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $65,403 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $124,133 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $252,915 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $327,013 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $462,350 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019107449$17,675
20203451,728$65,403
20216093,113$124,133
20227485,134$252,915
20239528,328$327,013
20241,15514,946$462,350

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$317K$633K2015 Drug cost: $5,492 (USD; Tot_Drug_Cst)2016 Drug cost: $41,657 (USD; Tot_Drug_Cst)2017 Drug cost: $118,781 (USD; Tot_Drug_Cst)2018 Drug cost: $167,898 (USD; Tot_Drug_Cst)2019 Drug cost: $57,346 (USD; Tot_Drug_Cst)2020 Drug cost: $55,612 (USD; Tot_Drug_Cst)2021 Drug cost: $112,978 (USD; Tot_Drug_Cst)2022 Drug cost: $295,852 (USD; Tot_Drug_Cst)2023 Drug cost: $327,854 (USD; Tot_Drug_Cst)2024 Drug cost: $633,088 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151345$5,492
201653178$41,657
201774241$118,781
201843132$167,898
201966140$57,346
2020191562$55,612
2021356892$112,978
20224031,262$295,852
20234791,415$327,854
20246391,704$633,088

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths311361$68
11102Biopsy of related skin growth, first growth383451$56
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more665880$55
17000Destruction of precancer skin growth, 1 growth553707$31
17003Destruction of precancer skin growth, 2-14 growths3992,070$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab14392$148,548
Dupixent PenDupilumab30840$112,626
FluorouracilFluorouracil1624,923$12,532
Clobetasol PropionateClobetasol Propionate1373,762$4,201
KetoconazoleKetoconazole2267,183$3,856

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.183$3,312Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kaitlin Ann Schiavo, MD?

Tedicare shows public-source Medicare data for Kaitlin Ann Schiavo, MD (NPI 1508248576), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kaitlin Ann Schiavo, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kaitlin Ann Schiavo, MD?

Kaitlin Ann Schiavo, MD is linked to DERMATOLOGY CENTER OF COLUMBIA, LLC (billing NPI 1982261947) in the available physician profile data.

Does Kaitlin Ann Schiavo, MD have Open Payments data?

Kaitlin Ann Schiavo, MD has 183 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.